Spiperone

CAS No. 749-02-0

Spiperone( Spiperone | E 525 | E-525 | E525 | R 5147 | R-5147 | R5147 | NSC 170983 )

Catalog No. M15854 CAS No. 749-02-0

A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 52 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Spiperone
  • Note
    Research use only, not for human use.
  • Brief Description
    A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
  • Description
    A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of schizophrenia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Spiperone | E 525 | E-525 | E525 | R 5147 | R-5147 | R5147 | NSC 170983
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    749-02-0
  • Formula Weight
    395.47
  • Molecular Formula
    C23H26FN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C1NCN(C2=CC=CC=C2)C13CCN(CCCC(C4=CC=C(F)C=C4)=O)CC3
  • Chemical Name
    8-(4-(4-fluorophenyl)-4-oxobutyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zheng LT, et al.J Neurochem. 2008 Dec;107(5):1225-35.
molnova catalog
related products
  • Gemcitabine monophos...

    Gemcitabine monophosphate disodium salt is a monophosphate derivative of Gemcitabine.

  • Medifoxamine

    Medifoxamine (LG 152) is a selective non-monoamine oxidase inhibitor that exhibits antidepressant activity through inhibition of 5 HT reuptake.Medifoxamine preferentially inhibits dopamine reuptake.

  • Dexpramipexole

    A partial/full agonist of dopamine receptor with Ki of 3.9/2.2/0.5/5.1 nM for D2S/D2L/D3/D4, respeectively.